Abstract
A novel MYB::PAIP1 oncogenic fusion in pediatric blastic plasmacytoid dendritic cell neoplasm (BPDCN) is dependent on BCL2 expression and is sensitive to venetoclax.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have